|
2025
|
Invention
|
Embolic microspheres. Functionalized embolic microspheres may be employed as a platform for radio... |
|
|
Invention
|
Novel compositions of matter comprising proteins that incorporate pfs230 or pvs230 domain 1 (pfs2... |
|
|
Invention
|
Use of lmo4 to bolster stemness and antitumor efficacy of t-cells. The present invention relates ... |
|
2024
|
Invention
|
Broadly neutralizing antibodies against sars-cov-2 and sars-cov variants. Disclosed are monoclona... |
|
|
Invention
|
N-methyltransferase and their therapeutic uses. NN-methyltransferase (NNMT) which have a triazolo... |
|
|
Invention
|
Oxabicycloheptanes for modulation of immune response.
The present invention provides a method of... |
|
|
Invention
|
Rsv vaccine bearing a polynucleotide which is de-optimised and de-attenuated. Provided is a polyn... |
|
|
Invention
|
Systems and methods for clinical artificial intelligence with patient-reported multi-modal audio ... |
|
|
Invention
|
Quantitative optical coherence tomography angiography. By acquiring sequences of data associated ... |
|
|
Invention
|
Modified pigment epithelium-derived factor peptides and methods of use. Provided herein are compo... |
|
|
Invention
|
Broadly neutralizing influenza hemagglutinin stem-directed antibodies. Monoclonal antibodies and ... |
|
|
Invention
|
Development of broad-spectrum anti-opioid vaccines. Provided herein are vaccine compositions comp... |
|
|
Invention
|
Neutralizing and protective monoclonal antibodies against respiratory syncytial virus (rsv). Anti... |
|
|
Invention
|
Influenza neuraminidase active site proximity assay (naspa) for rapid profiling of inhibitory ant... |
|
|
Invention
|
Immunogenic compositions comprising full-length influenza virus neuraminidase protein subunits an... |
|
|
Invention
|
Dna methylation-based cancer diagnostics. Disclosed herein are methods for classifying a tumor us... |
|
|
Invention
|
Prazole-based antiviral therapeutics. 161622nn- group where n is an integer from 1 to 6, a divale... |
|
|
Invention
|
Three-dimensional tuberculoma bioplatform and uses thereof. Provided herein is a 3-dimensional bi... |
|
|
Invention
|
Fused heterocycles for treating neurodegenerative diseases. Disclosed herein are aspects of compo... |
|
|
Invention
|
Nk cells or t cells expressing chimeric hematopoietic growth factor receptors and methods of use.... |
|
|
Invention
|
Brincidofovir for treatment of multiple sclerosis. The invention features methods of treating mul... |
|
|
Invention
|
Bioreactor system. A bioreactor vessel platform for submersion in a bioreactor vessel or petri di... |
|
|
Invention
|
Analogues of n-lactoyl-phenylalanine, methods of synthesis, and methods of use. N-Lactoyl-Phenyla... |
|
|
Invention
|
A molecular scaffold for depleting hrpn13 and a select group of ken box proteins. The invention p... |
|
|
Invention
|
Gait assistance systems and methods of control thereof. Determining predicted torque values for a... |
|
|
Invention
|
Stabilized sars-cov-2 s antigens. Provided herein are engineered protein comprising stabilized co... |
|
|
Invention
|
Human parainfluenza virus immunogenic molecules. Disclosed are live-attenuated human parainfluenz... |
|
|
Invention
|
Viral strain serology assays. The invention relates to methods and kits for determining a SARS-Co... |
|
|
Invention
|
Polyfluorinated thalidomide analogs and uses thereof. Polyfluorinated thalidomide analogs have a ... |
|
|
Invention
|
Method and system for rapid spectral unmixing using spectrally interpolated background reduction.... |
|
|
Invention
|
Rapid method for producing antibodies. The present disclosure relates to a rapid method for produ... |
|
|
Invention
|
Identification of sequence variants of the ervmer34-1 sequence family and use in anti-cancer ther... |
|
|
Invention
|
Bispecific antibodies that broadly target coronaviruses. Disclosed are bispecific antibodies, inc... |
|
|
Invention
|
2b serotonin receptor antagonists, pharmaceutical compositions thereof, and methods of use thereo... |
|
|
Invention
|
Kinase inhibitors. Disclosed is a class of kinase inhibitors of formula (I) or formula (II). Rela... |
|
|
Invention
|
Fully human monoclonal antibodies and chimeric antigen receptors against cd276 for the treatment ... |
|
|
Invention
|
Humanized 40h3 antibody. e.ge.g., humanized monoclonal antibodies and antigen binding fragments) ... |
|
|
Invention
|
Uses of iron chelators for treating stuttering. Provided herein are uses of iron chelators to tre... |
|
|
Invention
|
Shipping container for system supporting live cells. A shipping container for the support and shi... |
|
|
Invention
|
T cell receptors targeting ras with g12d, g12r, or g12v mutation. Disclosed are isolated or purif... |
|
|
Invention
|
Using machine learning and/or neural networks to validate stem cells and their derivatives (2-d c... |
|
|
Invention
|
Bicistronic chimeric antigen receptors and their uses.
An embodiment of the invention provides c... |
|
2023
|
Invention
|
Combination of angubindin-1 abd chemotherapy for the treatment of cns malignancies. The invention... |
|
|
Invention
|
Fused diazepines as agonists of the insulin-like 3 (insl3) peptide receptor rxfp2 and methods of ... |
|
|
Invention
|
Preparation of isotopically labeled ketoglutarates and methods of hyperpolarization through signa... |
|
|
Invention
|
Gingerenone a prodrugs as sensotherapeutics and methods of use. B is an amino acid side chain. Th... |
|
2022
|
Invention
|
Improved gene therapy constructs for the treatment of propionic acidemia caused by mutations in p... |
|
|
Invention
|
Next generation transpososomes.
Disclosed herein is a modified transposase, comprising a core pi... |
|
|
Invention
|
Methods and systems for analyzing target engagement data from biological assays.
The disclosure ... |
|
|
Invention
|
Self-assembling nanoparticles based on amphiphilic peptides.
The present disclosure relates to a... |
